Shengtai Pharmaceutical financials at a glance
Year | Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2004 | 2005 | 2006 | 2022 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rev. | Revenue |
|
51.71M | 90.87M | 73.32M | 115.95M | 171.72M | 179.03M | 216.45M | 221.39M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 20.00M | 24.86M | 36.03M | 0.00M | 0.00M |
GM % | Gross Margin % |
|
23.55% | 22.29% | 10.26% | 15.25% | 13.47% | 9.68% | 10.16% | 8.55% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 17.56% | 21.33% | 23.48% | 0.00% | 0.00% |
OM | Operating Margin |
|
14.51% | 14.16% | -1.98% | 6.38% | 7.76% | 3.07% | 3.35% | 2.59% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.19% | 8.29% | 12.85% | 0.00% | 0.00% |
EPS | Earnings Per Share |
|
0.00 | 0.00 | 0.00 | |||||||||||||||||
Div. | Dividends |
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sha. | Shares |
|
0m | 9.48m | 9.55m | 9.59m | 9.59m | 9.59m | 9.59m | 9.59m | 9.59m | 9.59m | 9.59m | 9.59m | 9.59m | 9.59m | 0m | 0m | 0m | 0m | 0m | 0m |
OCF | Operating Cash Flow |
|
8.35M | 5.49M | -1.29M | 9.58M | 5.07M | -23.74M | -3.31M | -36.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 2.02M | 0.71M | 6.53M | 0.00M | 0.00M |
FCF | Free Cash Flow |
|
-9.92M | -10.94M | -8.28M | -5.93M | -1.52M | -23.97M | 0.00M | -37.03M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | -1.23M | -2.23M | -0.86M | 0.00M | 0.00M |
FCFS | Free Cash Flow Per Share |
|
-1.93 | -1.18 | -0.82 | -0.62 | -0.16 | -2.50 | -0.35 | -3.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.17 | -0.44 | -0.17 | 0.00 | 0.00 |